and for antibody by indirect immunofluorescence (1, 6). Over 20
Strain differences in virulence for types la, I1 and 111 group B streptococci were assessed using an animal model of group B streptococcal disease. Human isolates of group B streptococci, which have been shown to have strain specific differences in opsonic requirements, were also found to exhibit differences in virulence within the same serotype. Serum, possessing opsonic and protective antibody against one strain, often did not have activity against other strains of the same serotype. Our results point to a direct correlation between strain resistance to opsonization and increased virulence within a given serotype. different sera were employed in these studies. ~e~i e s e n t a t i v e experiments are shown. For opsonic assays, sera was heated at 56°C for 1 h and then reconstituted with whole human complement as previously described (6) .
Rabbit antibody to the group specific carbohydrate of group B organisms was purchased from Difco Laboratories (Detroit, MI). Typing serum was prepared by slight modifications of Lancefield's techniques as previously described (6) . All sera were absorbed with equal volumes of heterologous type organisms to remove cross reactions (6) .
Chemiluminescence procedure. This procedure has been described in detail elsewhere (6) . Briefly, s&a to be tested for opsonic Speculation antibody activity were incubated at 37OC for 30 min with a Some strains of group B appear to be more virulent reference 0' wild type (recent clinical isolate) strain of group B than others in experimental animals. -,-hese strains are not uni-streptococci types Ia, 11, or 111 at a ratio of 0.5 ml of bacteria (At f o d y susceptible to the actionof antibody andcomplement. Such 108-1.0 log colony-foming units per ml) m1 of strain differences in virulence and opsonic requirements must be Se"m. The O~sonized bacteria were washed considered in the development of active or passive immunotherapy ~n b o u n d antibody. In dark adapted scintillation vials, polymerof this most fulminant of neonatal diseases.
phonuclear leukocytes (0.5 ml at lo7 cells/ml) were mixed with 0.5 ml of the bacterial suspension. The volume was adjusted to 3.5 ml with sterile PBS. The vials were capped, and placed in a Group B streptococci continue to be a major cause of morbidity Beckman LS-100~ liquid scintillation counter (Beckman Instruand mortality in neonates and in other patients with compromised ment% Inc.7 Fullerton, CA) and counted at approximately 10 min host defense mechanisms (2, 13) . In previous studies we have intervals for a tot?l of 100 min. Chemiluminescence (CL) peaks of shown strain specific differences in opsonic requirements for type 7500 cpm or greater were always associated with phagocytic I1 and I11 group B streptococci (8, 18) . Using a chemiluminescence uptake as detmnined by visual mkroscopic examination (61, opsonic assay (6), a radiolabeled bacterial uptake technique (l), which was performed as described below. Phagocytic uptake was and an indirect immunofluorescence method (6), we have system-also assessed in selected sera by the radiolabeled bacterial uptake atically examined a number of sera for opsonic activity to multiple technique described below (1). The correlation coefficient between strains of group B streptococci isolated from infected infants. We CL peaks and i x x~~l a t e d CPm approximates 0-79. It should be found some strains to be highly resistant to opsonization by noted that the level of chemiluminescence, which indicates the antibody containing serum (18). The strains which have this presence of functional opsonic antibodies in these studies, is higher pattern of resistance to opsonization are considered to be resistant than in previously published repofis (6) and reflects a higher strains. In contrast to these isolates, other strains are opsonized by overall background from an older scintillation apparatus. Thus, the majority of antibody containing sera examined and are con-bacterial uptake using the visual and radiolabeled technique was sidered sensitive strains (8, 18) . associated with CL peaks of 7500 rather than 6500 cpm. The purpose of this study was to assess the biologic significance ViSUal ~~C~O S C O~~C e~aminati~n of reaction mixtures. After Schof these differences in opsonic requirements using an animal tillation counting, each reaction mixture was centrifuged at 5000 model of group B streptococcal disease. Resistance to opsonization T m for 5 m h the supernate was removed, and the cell button was found to correlate closely with virulence.
was resuspended in a small volume of PBS. An aliquot of this mixture was placed on a clean microscope slide and air dried. The MATERIALS AND METHODS slides were futed for 10 min in 1 W o methanol and stained with Giemsa (Harleco, Gibbstown, NJ, 150 in distilled water) for 1 h. Preparation of organisms. Human isolates of group B strepto-Each slide was examined microscopically under oil immersion to cocci, types Ia, 11, and 111 sensitive (S) or resistant (R) to opsoni-visually assess phagocytosis of the organisms.
zation by most antibody containing (Ab') sera were cultured in Radiolabeled bacterial uptake technique. Bacteria were prepared Todd-Hewitt (Difco Laboratories, Detroit, MI) broth at 37°C for by incubation on Todd-Hewitt media containing [3H]-leucine (5 14 h and adjusted to I x lo9 cfu per ml in phosphate buffered mCi/ml) at 37OC for 24 h, heat-killed, washed 3 times in PBS and saline (PBS) as previously described (6) . These organisms were adjusted to 3.3 x 10' cfu/ml (1). Aliquots of bacteria were stored used immediately for infecting the newborn rats.
at -20°C prior to use and at that time opsonized at 37°C for 30 Serum treatment. Fresh serum or serum frozen immediately min as described above. Opsonized bacteria were washed once after collection at -70°C was assessed for opsonic activity by a and resuspended to the original volume in medium 199 (Microchemiluminescence and a radiolabeled bacterial uptake technique biological Associates, Walkersville, MD). Phagocytic uptake by human polymorphonuclear leukocytes (PMN) was determined by a modification of the method previously described by Mandel(14) and Anthony and coworkers (3) . Monolayers of PMN were prepared by incubating 0.3 ml leukocyte suspension on 18 x 18 mrn glass coverslips at room temperature for 30 min. Nonadhering cells were washed off with PBS and 0.3 ml(1 x 10' organisms) of the opsonized, labeled bacterial suspensions added to each coverslip. Control suspensions contained bacteria alone, PMNs alone and unopsonized bacteria plus PMN. At intervals of 1, 10,20,30, 40, and 50 rnin, coverslips were washed with PBS, placed in scintillation vials with 5.0 ml of Aquasol and counted 5 min in a Beckrnan LS-100c scintillation counter. The monolayers appeared evenly distributed by microsco ic examination. The number of B adherent cells (5 x lo5-1.5 x 10 ) was estimated by counting cells in 5 random grids at 400 power and multiplying the average by the number of grids (20227) per coverslip. The accumulated cpm/ lo6 adherent PMNs were calculated at each interval and plotted against time. Controls were bacterial suspensions added tdcoverslips without cell monolayers or with cells but unopsonized bacteria and showed 1.0 accumulation of radioactivity.
Preparation of group B streptococcal antigen. Cold trichloroacetic acid extracts of the reference strains of group B streptococci were prepared by slight modifications of the procedures of Lancefield (9, 10) and Lancefield and Freimer (1 1). Briefly, strains were inoculated into enriched Todd-Hewitt broth as described by Baker and Kasper (4) , and incubated at 37OC for 18 h. The bacterial pellet was then extracted in 2.5% cold trichloroacetic acid (TCA) in an ice water bath with sonication. Such mild treatment with TCA does not significantly alter the sialic acid content of saline or buffer extracted antigen (21) . The type specific antigens were then separated from group specific substances by fractional alcohol precipitation utilizing 1.5 volumes of alcohol. All extracts were examined for the presence of type specific and group specific substances by capillary precipitin (10) and counterimmunoelectrophoresis (7) .
Semi-quantitative capillary precipitin procedure and counterimmunoelectrophoresis (CIE). The capillary precipitin tests were performed by mixing equal volumes of absorbed rabbit hyperimmune type-specific antiserum and the antigen to be tested in sterile capillary tubes (10) . Typing reactions were read in 10 min; formation of a precipitate was interpreted as a positive test. Varying dilutions of the antigen mixtures were used in an effort to roughly quantitate the type-specific antigen present. The final dilution of an extract yielding a precipitin band with a standard serum was used as an estimate of the relatively quantity of the antigen present in the undiluted extract. In these experiments, strains were grown for 18 h in Todd-Hewitt broth (250 ml) and adjusted to an optical density of 0.7 at 620 nm. The bacterial pellet was then extracted with a standard volume of cold 2.5% TCA as described above. Standardized volumes of the extracts were used in the capillary precipitin tests and the CIE procedure.
Counterimmunoelectrophoresis of standardized broth culture filtrates or extracts of organisms were performed as described by Hill and coworkers (7) . Type I1 and 111 R and S strains were grown in enriched Todd-Hewitt broth, adjusted to a standard optical density and the culture filtrate or TCA extracted antigens were tested by CIE. Standard absorbed rabbit typing antisera against type I1 or 111 was placed in the well nearest the anode while the culture filtrates were diluted and placed in the well nearest the cathode. Electrophoresis was camed out for 30 min at 5-7 mA per 1 x 3 inch microscope slide. Slides were then incubated in the cold overnight and examined the next day with a hand lens. The highest dilution of extract produce a detectable precipitate with a standard antiserum is used as an estimate of the quantity of the antigen present.
Neonatal rat infections. Outbred neonatal Sprague-Dawley rats were studied within 12 h from the time of birth. Animals were inoculated intraperitoneally with 5 pl of PBS containing 5 x lo6 streptococci. In the protection studies, the animals also received separate equal volume injections of serum. The rat litters were observed at 6-h intervals for mortality. Surviving rats were observed for a total of 3 wk as previously described (16) .
Statistical analysis. Comparison of significance of differences between survival values in the animal studies was performed by use of the Fisher Exact test.
RESULTS
The survival rate in 28 unprotected rats infected with a strain of type 111 group B streptococci which was sensitive (S) to opsonization by most serum containing antibody as determined by indirect immunofluorescence was 29%. In contrast, animals who received a strain of type 111 group B streptococci, which was resistant to opsonization had a 100740 mortality (Fig. I) . Similar differences in host susceptibility to sensitive and resistant strains of type Ia and type I1 group B streptococci were also demonstrated and are depicted in Fig. 2 ; thus, resistance to opsonization appears to be associated with increased virulence in this animal model.
Because the type specific polysaccharide has been shown to be one of the antiphagocytic or virulence factors of group B streptococci, we next measured the capsular polysaccharide content of human isolates of sensitive and resistant strains of types Ia, I1 and I11 group B streptococci by the quantitative capillary precipitin test and CIE using standardized extracts of the strains prepared as described under methods. Type specific, cross absorbed rabbit antiserum was used in Lhese semiquantitative studies. Ten human isolates of group B streptococci were evaluated. As shown in Table  1 , some sensitive strains with low virulence exhibited a high polysaccharide content as determined by the precipitin tiikr whereas some resistant strains with hieh virulence exhibited a low " polysaccharide content. Thus, we could not demonstrate an association between extractable capsular polysaccharide content and virulence in this animal model. Additional studies (Table 1) failed to show a difference in the amount of type specific or group B polysaccharide released into the growth media between sensitive and resistant strains (as determined by CIE precipitin analysis with standard absorbed antisera).
The effect of antibody on the virulence of these strains was determined next. The survival rate in 39 neonatal rats infected with type IIIS group B streptococci who received human serum containing antibody directed against the organism by indirect immunofluorescence antigen was 65%. In contrast, none of the type IIIR infected animals who received the same human serum survived (Fig. 3) . The R strain was also coated with antibody as determined by the indirect immunofluorescence assay. We also evaluated the susceptibility of the R and S strain to opsonization by this same antibody containing serum using the chemiluminescence assay. A significant difference in chemiluminescence pro- duction was observed when control PMNs were challenged with the preopsonized 111s strain (10,500 cpm) compared to the preopsonized IIIR strain (7,300 cpm) (Fig. 4) . Phagocytic uptake as determined by radiolabeled bacterial uptake and visual microscopic examination was associated with peak CL values of 7,500 cpm or greater in these experiments (see "Materials and Methods"). Thus, the serum contained excellent opsonic and protective antibody against one type I11 strain but did not have activity against another strain of the same serotype. These results are representative of those obtained with 12 additional human sera possessing similar activity.
After examining a number of human sera, three were found which did opsonize the IIIR strain. The peak CL value with the IIIR strain opsonized in a representative serum sample from this group was 8500 (Fig. 4) . This serum offered protection in the neonatal rats infected with the IIIR strain when compared to the unprotected group (P < 0.002).
DISCUSSION
Our results indicate that human isolates of group B streptococci, types Ia, I1 and I11 which have specific differences in opsonic requirements also exhibit differences in virulence within the same serotype when tested in this animal model. The virulence of S. pneumoniae (15) and Hemophilus influenzae type b (20) appears to
T I M E ( H O U R S )
Fig. 4 . Effect of antibody containing serum on neonatal rat survival with type llIR group B streptococcal infection. n = number of rats infected. This serum possessed excellent opsonic activity for t h e IIIR strain (C1 = 8500 cpm).
be associated with thicker capsules and the amount of physically integrated capsular polysaccharide. Presumably the amount of capsular polysaccharide increases resistance to opsonization and blood serum, clearance. Strains of group B streptococci are known to vary in their content of type specific antigen and in some instances are missing this substance (10) . Previous studies with group B streptococci have failed to show a correlation between capsular polysaccharide content and susceptibility to opsonization b y a n t i b~d~c o n t a i n i n~ sera (18). similarly, we foundno correlation between virulence and capsular polysaccharide content of individual strains of the same serotype. Neither could we demonstrate differences in the amount of type specific antigen released into the growth media by relatively virulent or nonvirulent strains. These results indicate that, in this animal model, group B streptococcal type specific polysaccharide content or release is not directly related to the straih's virulence, nor does it directly relate to resistance to opsonization.
Protection against group B streptococci presumably depends on opsonic antibodies specific for surface polysaccharides and protein antigens that occur in the five serotypes (1 1, 12, 19) . Serum absorption studies with TCA and hot HCI extracts remove some but not all opsonins to these organisms (6, 11, 12) . Our previous studies (17, 18) with whole organisms and type 111 carbohydrate extracts indicate that antibody to type specific polysaccharide is important in opsonizing both serum resistant and serum sensitive strains. It is not the only antibody important in opsonization and protection, however. Fischer and coworkers (5) have recently shown that antibody to the type-specific antigen of type 111 group B streptococci opsonizes some but not all type 111 strains. Similarly, the present studies indicate that serum possessing excellent opsonic and protective antibody against one strain often did not have protective activity against other strains of the same serotype (at least 12 different sera). Our results in this animal model also point to a direct correlation between strain resistance to opsonization and increased virulence within a given serotype. These critical differences in opsonic requirements of the various strains and the variation in protective efficacy of antibody directed against different components of group B organisms must be considered in any attempt at providing active or passive immunity to the neonate.
